Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4/A Grant or award President & CEO acquired 26,467 shares (grant or award)
  3. 4/A Grant or award President & CEO acquired 0 shares (grant or award)
  4. 4 Open-market buy Chief Financial Officer bought 2,246 shares at $4.30 ($9,658)
  5. 4 Grant or award President and CEO acquired 26,367 shares (grant or award)
  6. 4 Grant or award Director acquired 13,252 shares (grant or award)
  7. 4 Open-market buy Director bought 754 shares at $3.98 ($3,001)
  8. 4 Grant or award President and CEO acquired 26,467 shares (grant or award)
  9. 4 Grant or award Director acquired 7,045 shares (grant or award)
  10. 4 Grant or award General Counsel & Secretary acquired 13,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 3,769 shares at $3.98 ($15,001)
  13. 4 Open-market buy 10% owner bought 181,800 shares at $2.75 ($499,950)
  14. 4 Open-market buy Director bought 6,281 shares at $3.98 ($24,998)
  15. 4 Open-market buy President & CEO bought 12,563 shares at $3.98 ($50,001)
  16. 4 Open-market buy CSO & COO bought 628 shares at $3.98 ($2,499)
  17. 4 Open-market buy Director bought 6,281 shares at $3.98 ($24,998)
  18. 4 Open-market buy General counsel and secretary bought 754 shares at $3.98 ($3,001)
  19. 4 Open-market buy Director bought 3,769 shares at $3.98 ($15,001)
  20. 4 Open-market buy Chief Financial Officer bought 754 shares at $3.98 ($3,001)

Page 6 of 28 · 551 filings